| Drug Name |
Darbepoetin alfa |
| Drug ID |
BADD_D00583 |
| Description |
Human erythropoietin with 2 aa substitutions to enhance glycosylation (5 N-linked chains), 165 residues (MW=37 kD). Produced in Chinese hamster ovary (CHO) cells by recombinant DNA technology. |
| Indications and Usage |
For the treatment of anemia (from renal transplants or certain HIV treatment) |
| Marketing Status |
Prescription |
| ATC Code |
B03XA02 |
| DrugBank ID |
DB00012
|
| KEGG ID |
D03651
|
| MeSH ID |
D000068256
|
| PubChem ID |
Not Available
|
| TTD Drug ID |
D02LVZ
|
| NDC Product Code |
55513-005; 55513-006; 55513-028; 55513-003; 55513-098; 55513-110; 55513-023; 55513-004; 55513-002; 55513-021; 55513-111; 55513-032; 55513-025; 55513-057; 55513-027 |
| Synonyms |
Darbepoetin alfa | Novel Erythropoiesis Stimulating Protein | NESP | Darbepoietin alfa | Aranesp | Aranest | KRN 321 | KRN321 | KRN-321 |
